Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Treatment by Shannon Mcweeny
Introduction
Shannon Mcweeny is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of cancer treatment, particularly in addressing challenges associated with venetoclax-resistant acute myeloid leukemia. His innovative approaches aim to improve therapeutic outcomes for patients facing this difficult condition.
Latest Patents
Shannon Mcweeny holds a patent for "Methods of treating venetoclax-resistant acute myeloid leukemia." This invention focuses on novel treatment methods for patients with low expression of the TP53 protein or those with mutations in the TP53 gene. The methods involve administering a therapeutically effective amount of an NTRK/ALK/ROS1 inhibitor or a pharmaceutically acceptable salt thereof.
Career Highlights
Shannon is affiliated with Oregon Health & Science University, where he conducts research and develops innovative treatment strategies. His work is pivotal in advancing the understanding and management of acute myeloid leukemia, particularly in cases resistant to standard therapies.
Collaborations
He collaborates with esteemed colleagues, including Jeffrey Tyner and Tamilla Nechiporuk, to further enhance the research and development of effective cancer treatments.
Conclusion
Shannon Mcweeny's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to inspire advancements in the medical field.